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a b s t r a c t
The aim of this study was to conduct a carcinogenic risk assessment for exposure to polycyclic aromatic
hydrocarbons (PAHs) via routes of inhalation and dermal contact. Concentrations of 19 PAH species were
determined during a heating period at a site in the city of Balikesir, Turkey. Two questionnaires were
administered to a sample of inhabitants to determine time-activity budgets and demographic informa-
tion. The assessment was conducted for each participant and Balikesir population by deterministic and
probabilistic approaches, respectively. Monte Carlo simulation was implemented to determine the
population exposure-risk probability distributions. The estimates were based on benzo[a]pyrene
equivalent (BaPeq) total PAH concentrations calculated using toxic equivalency factors. The mean and
median BaPeq concentrations of gaseous and particulate phases were 3.25 and 1.34, and 38.5 and
34.0 ng/m3, respectively. Carcinogenic risk for inhalation exposure route was estimated by using two
different slope factor values (3.9 and 304.5 (mg/kg-day)1), recommended by two different organiza-
tions, resulting in two (order(s) of magnitude apart) population risk ranges: 1.32107–2.23104,
and 1.61105–7.95103, respectively. The population risks associated with dermal exposure were
lower compared to those of inhalation, ranging from 6.58109 to 2.57106. The proportion of the
population with risks higher than the general acceptable level (1.0106) was estimated as 499
percent, for inhalation, and as 28 percent for dermal exposure route.
& 2014 Elsevier Inc. All rights reserved.
1. Introduction
Polycyclic Aromatic Hydrocarbons (PAHs) are the most fre-
quently detected semi-volatile organic compounds (SVOCs) in
ambient air with higher concentrations compared to other common
groups of SVOCs (such as polychlorinated biphenyls and polybro-
minated diphenyl ethers). PAHs and their derivatives are known to
be generated by incomplete combustion of organic materials and
fossil fuels (Li et al., 2013). Therefore, there are abundant number of
sources such as motor vehicles and residential heating, resulting in
high ambient air concentrations in urban areas, especially mega
cities. PAHs have many adverse health effects. After chronic expo-
sure to PAHs, damage of organ systems, cancer, reproductive effects
can occur. Although presence of more than 100 PAH compounds in
nature are known, 16 of them have been accepted as priority
compounds because of their high carcinogenic and toxic effects.
The list includes naphthalene (Nap), acenaphthylene (AcPy), ace-
naphthene (Acp), fluorene (Flu), phenanthrene (PA), anthracene
(Ant), fluoranthene (FL), pyrene (Pyr), benzo[a]anthracene (BaA),
chrysene (Chry), benzo[b]fluoranthene (BbF), benzo[k]fluoranthene
(BkF), benzo[a]pyrene (BaP), indeno[1,2,3-c,d]pyrene (Ind), dibenzo
[a,h]anthracene (DahA), benzo[g,h,i]perylene (BghiP) (USEPA, 2010).
Among the 16 compounds, BaP is determined as the most impor-
tant carcinogenic PAH compound. Thus, it is accepted as model
compound in cancer studies (Luch and Baird, 2010; Akcha et al.,
2003). Since PAH compounds have different level of carcinogenic
effects, three approaches were developed in order to estimate
the risk of a PAH mixture, and to prevent overestimation of
carcinogenic risk (Jung et al., 2010). These approaches are Toxic
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Equivalency Factors (TEFs), the comparative potency of mixtures,
and the use of BaP as a surrogate (Pufulete et al., 2004; IPCS, 1998).
Health risk assessments were conducted for PAH compounds in
urban areas around the world because of their high atmospheric
concentrations. To date, information on PAH air pollution in
Turkey is limited. In the limited number of studies that exist, high
atmospheric PAH concentrations have been measured in several
locations such as Bursa (Esen et al., 2006; Birgul et al., 2011),
Eskisehir (Ari, 2008), Istanbul (Hanedar et al., 2011), Izmir
(Demircioglu et al., 2011), and Konya (Ozcan and Aydin, 2009)
which are large cities, smallest of which with a metropolitan
population of 630,000 (TUIK, 2010); Aliaga (Bozlaker et al., 2008;
Kaya et al., 2012) and Iskenderun (Ozgunerge Falay et al., 2013)
which are locations of intense industrial activity; Kocaeli (Gaga
et al., 2012) a large city with intense industrial activity; and
Zonguldak (Akyuz and Cabuk, 2008), a relatively small city with
a population of about 109,000 (TUIK, 2010) but that has intense
coal mining activity and iron-steel industry about 15 km far away.
Nevertheless, only one study conducted an exposure-risk assess-
ment (Gaga et al., 2012), which estimated 41.0103 total
cancer risk levels using the unit risk approach.
The objective of this study was to assess health risk levels for
inhalation and dermal contact exposure to ambient air PAHs in a
relatively small city, Balikesir, Turkey, where residential heating
and traffic are the only major PAH sources. Urban atmospheric PAH
concentrations were measured in a heating period, and time-
activity information of a sample of Balikesirians were collected to
estimate the individual carcinogenic risks. A Monte Carlo simula-
tion was conducted to estimate the population risks, for which
sensitivity and uncertainity analyses were also conducted.
2. Materials and methods
2.1. Sampling site
Balikesir is a city in western Turkey, with a population of approximately
266,000 (TUIK, 2010). Agriculture is the main economy driver. Some small and
medium scale industrial enterprises are spread to districts, e.g., production of
transformers, paper, cement, marble, metal products, agricultural machinery,
electrical equipment, man-made fabrics, and fertilizer. Samples were collected at
a station (Necatibey Egitim Fakultesi) in the downtown campus of Balikesir
University, which is located between the city center and the residential areas.
Therefore, the sampling site should reflect both of the areas.
The city's climate is a transitional climate between the Mediterranean and the
Balkan. The average temperature during sampling period was 10.5 1C, while the
annual average temperature is 14.6 1C (1980–2006) (Turkish State Meteorological
Service, 2014). The northern cold weather systems during the winter and the
southern hot and dry weather during the summer influence the city (Koc, 2001;
Tagıl, 2004). Residental heating is fueled by natural gas and coal with roughly
40 and 60 percent contribution, respectively.
2.2. Sample collection and analysis
PAH samples were collected on a diurnal basis (n¼26) during the heating
period between October 2009 and March 2010 at a station located in the down-
town campus of Balikesir University. Particle and gas phase samples were collected
on glass wool filters (GWF), and polyurethane foam (PUF), respectively, with a high
volume sampler model GPS II (Thermo-Andersen Inc.) collecting 300 m3 of air per
sample. Gas phase air samples (PUF cartridges) were Soxhlet extracted for 24 h
with a mixture of 1:4 dichloromethane (DCM):petroleum hexane. Particle phase air
samples (GWF) were ultrasonically extracted for 30 min with DCM. Prior to
extraction, all samples were spiked with PAH surrogate standards to monitor the
analytical recovery efficiencies. After concentrating the extracts of PUF cartridges to
10 mL and the extracts of GWF to 5 mL using a rotary evaporator, samples were
cleaned up and fractionated on a florisil column with a mixture of 1:4 hexane:
toluene. PAHs were eluted, and concentrated under a stream of N2 to 1 mL in
hexane. Gas chromatography–mass spectrometry (GC–MS) was used to detect and
quantify PAH compounds in the collected samples after the preparation procedure
(extraction, clean up, concentration). Selective ion monitoring mode (SIM) was
used for analysis. Details regarding sampling and analysis can be found elsewhere
(Tecer et al., 2012). Concentrations of 19 PAH species were determined. These were
Nap, AcPy, Acp, Flu, PA, Ant, FL, Pyr, BaA, Chyr, BbF, BkF, BaP, Ind, DahA, BghiP, benzo
[e]pyrene (BeP), cyclo-penta[c,d]pyrene (CYC), anthanthrene (ATT).
Field blanks were collected and analyzed to determine background contamina-
tion. All blank levels were o10 percent of the samples. Sample concentrations were
blank corrected. Limits of Detection were calculated by adding three standard
deviations to the mean blank levels, which ranged from 0.007 ng/m3 for Chyr to
0.052 ng/m3 for BkF. Average recoveries were calculated using the surrogate
standards, which ranged from 75 percent for Nap, AcPy, Acp, and FL to 90 percent
for BbF, Ind, DahA, BgP, BaP, BkF, Flt, Pyr, BaA, and Chyr. A standard reference material
(SRM 1649a) was also used to check the analytical method. The average recoveries
from the SRM were 497 percent for Ant, FL, Pyr, BaA, Chyr, and BaP, and ranged
between 83 percent (Nap) and 94 percent (BgP) for the remaining compounds.
2.3. Questionnaires
Time-activity budgets and demographic information were collected from 63
participants in the city by administering two questionnaires. The first question-
naire, which inquired about demographics of occupants, was administered by the
investigators during a visit to their households. The second questionnaire was self-
administered by the primary participant for a week. Demographic data collected
included gender, age, education, income, homeland, and body weight. Time-activity
questionnaire aimed to collect the time daily spent with five different activity levels
of rest, sedentary, light, moderate, and heavy activity. Primary participants were
asked to keep track of the time spent with different activities during the day, and
administer the questionnaire at night. Seven-day averages were calculated for each
participant for use in exposure-risk assessment.
2.4. Exposure assessment
Exposure assessment was conducted for inhalation and dermal contact routes.
Chronic daily intake (CDI) was calculated (USEPA, 1997) as an estimate of inhalation
exposure for each PAH compound (i) and activity category (j):
iCDIi;j ¼
Ci  IRj  EDj  EF
BW  AT ð1Þ
where C is the contaminant concentration (ng/m3), IR is inhalation rate (m3/day),
ED is exposure duration (yr), EF is exposure frequency (days/yr), BW is body weight (kg),
AT is averaging time which was assumed as lifetime and calculated as ED365 days/yr,
and iCDI is inhalation chronic daily intake (ng/kg-day). Lifetime exposure was assumed
for the assessment (ED¼70 years). Since samples were collected only in a heating
period, the data represented one half of a year, and EF was taken as 180 days/yr.
A conservative approach was chosen by assuming a 100 percent penetration of outdoor
air into the buildings resulting in equal indoor and ambient air concentrations. The
mean [7SD] penetration used for homes of an urban area in a population PAH
exposure-risk study (90 [76] percent, Zhou and Zhao, 2014) shows that the above
assumptionwould not introduce considerable error into the estimated risks because the
uncertainty level only in the measured PAH concentrations are 410 percent, e.g.,
average recovery efficiency of sample extraction procedure ranges from 60 to 86 percent
which are acceptable by the standard method EPA TO 13A (Demircioglu et al., 2011;
Gaga et al., 2012). Furthermore, the mean BaPeq concentration indoor/outdoor ratio
reported for homes of the urban area (Zhou and Zhao, 2012) ranged from 0.94 to 1.11
(5th to 95th percentile). BaP is assumed as model compound for PAH mixture. Thus, all
concentrations of PAH compounds were expressed by BaPeq which was calculated based
on the set of TEFs proposed by Nisbet and LaGoy (1992) and Larsen and Larsen (1998),
shown in Table 1. The proposed values were based on the available literature on
carcinogenity with various routes of exposure.
Exposure by dermal contact was calculated as (USEPA, 1992)
dCDI¼ C  Kps  SA  ED  EF
BW  AT ð2Þ
where C is the contaminant concentration (ng/m3), Kps is permeability coefficient
(m/day), SA is exposed body surface area (m2), ED is exposure duration (yr), EF is
the exposure frequency (day/yr), AT is averaging time (yr), BW is the body weight
(kg), and dCDI is chronic daily intake (ng/kg-day). AT, ED, and EF were assumed as
the same values as in Eq. 1. Particle phase concentrations were determined for each
PAH compound, and the concentrations were used as contaminant concentrations
(C) in Eq. (2). Total body surface area was estimated in relation to the body weights
obtained from the questionnaire using Eq. (3) (Livingston and Lee, 2001)
SA¼ 0:1173  BW0:6466 ð3Þ
where BW is the body weight (kg), SA is total body surface area (m2). The body
segments including only hands (2.7 percent of SA) and heads (4.0 percent of SA)
were considered in dCDI calculation, because other body segments were covered by
clothes in the sampling period.
2.5. Risk assessment
An individual health risk assessment was conducted for the participants of this
study for both inhalation and dermal contact exposure routes. In addition, a
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population health risk assessment was conducted using Monte Carlo simulation
method. Cancer risk associated with PAH exposure is calculated using the following
equation (USEPA, 2005)
R¼ ∑
J
j
CDIj x SF ð4Þ
where R is probability of excess cancer risk, SF is slope factor of the chemical (ng/
kg-day)1, CDIj is the chronic daily intake (ng/kg-day) for each activity, j. Two SF
values of 3.9 and 304.5 (mg/kg-day)1 by CalEPA (2005) and WHO (1987),
respectively, were used to calculate risk for inhalation; whereas, the SF for dermal
absorption route was 12.0 (mg/kg-day)1 recommended by CalEPA (2005) for
ingestion. Crystal Ball software (v 4.0e) was used to carry out Monte Carlo
simulation to estimate population risks. The simulation is a computer-based
method of analysis that uses statistical sampling techniques to obtain a probabil-
istic approximation to the output of a mathematical equation or a model.
A probability distribution was used to depict the possible values for each variable
in the exposure-risk model. Kolmogorov–Smirnov (KS), and Anderson–Darling (AD)
tests were the aid to fit probability distributions to the measured data. The best
fitting distribution was selected among beta, exponential, gamma, normal, lognor-
mal, logistic, pareto, and Weibull distributions. The simulation was run for 10,000
trials producing 10,000 forecasts (or possible outcomes) which were used to
construct distributions that describe population exposure and risk. A sensitivity
analysis was also carried out by using the Crystal Ball software. In this study, rank
correlation coefficients between each input and output were computed to rank the
input parameters in terms of their effect on the output variables. Uncertainity
analysis was also conducted using the simulation software. The bootstrap method
was applied. Two hundred simulations were applied with 1000 trials each.
3. Results
3.1. Ambient air PAH concentrations
Gaseous phase and particle phase PAH concentrations were
measured. Fig. 1 shows the gaseous and particle phase PAH and
BaPeq concentration profiles. The mean, median, and 95th percen-
tile total PAH concentrations for gaseous phase were measured as
432, 261, and 1951 ng/m3, respectively. These statistics for total
particle phase concentrations were 187, 152, and 499 ng/m3,
respectively. The mean, median, and 95th percentile BaPeq con-
centrations for gaseous phase were 3.25, 1.34, and 21.1 ng/m3,
respectively. The BaPeq concentrations for particle phase were
measured as 38.5, 34.0, and 101 ng/m3, respectively.
3.2. Exposure and risk assessment
3.2.1. Individual exposure and risks
Individual exposures of the study participants were estimated
using personal data from the questionnaires and the concentra-
tions measured at the downtown station. Since concentrations
were not specific to each participant, exposures were calculated
for the mean, median, and 95th percentile BaPeq concentrations.
Table 2 presents the descriptive statistics of the estimated expo-
sures for inhalation and dermal exposure routes. Inhalation
exposure ranged between 1.5 and 7.0 ng/kg-day, while dermal
exposure ranged between 0.103 and 0.140 ng/kg-day based on the
mean BaPeq concentration. The majority of contribution to the
total exposure (92–99 percent) is from the inhalation route.
Individual carcinogenic risk of the study participants were
estimated with two different SFs which are by CalEPA (2005)
and WHO (1987). Carcinogenic risks were calculated for inhalation
and dermal exposure routes for the mean, median, and 95th
percentile BaPeq concentrations. The risk level calculated on the
basis of the mean concentration and SF by CalEPA (2005) ranged
between 5.89106 and 2.74105, while the risk levels cal-
culated on the basis of SF by WHO (1987) ranged between
4.60104 and 2.14103 for inhalation exposure. The risk level
for dermal exposure ranged between 1.23106 and 1.68106.
Descriptive statistics of the individual risk estimates are presented
in Table 2.
3.2.2. Population exposure and risks
Monte Carlo simulation was implemented to estimate popula-
tion exposure and risks for inhalation and dermal exposure routes.
Fitted distributions for each input variable to the exposure-risk
models, and their parameter values are presented in Table 3.
The estimated inhalation exposures ranged between 0.037 to
24.4 ng/kg-day, while the range for dermal exposure was from
3.7106 to 0.25 ng/kg-day.
Estimated risk frequency histograms and fitted distributions for
simulated population risks are shown in Fig. 2. The risk levels
calculated on the basis of SF by CalEPA (2005) for inhalation
exposure ranged between 1.32107 and 2.23104 (Fig. 2a),
whereas the risk levels calculated using the SF by WHO (1987) for
inhalation exposure ranged between 1.61105 and 7.95103
(Fitted distribution: Gamma, Scale¼8.16104, Shape¼1.67, Mean¼
1.36103, Median¼1.13103, 95th percentile¼3.33103). Risk
levels associated with dermal exposure ranged between 6.58109
and 2.57106 (Fig. 2b).
4. Discussion
Ambient air PAH samples were collected, and the profiles of
gaseous and particle phase PAHs were determined. The concen-
tration profiles of the two phases were different. The common and
dominant PAHs for gaseous phase were PA and Nap, as shown in
Fig. 1a. However, the dominant PAHs for particle phase were Ind,
Pyr and FL (Fig. 1b). According to the literature, three-ring and
four-ring PAH compounds are found in diesel exhaust particulates,
especially PA, Pyr, FL (Rogge et al., 1993). PA can also be found
abundantly in diesel exhaust vapor emissions (Westerholm and Li,
1994). Nap sources include coal combustion and burning of
organic materials, such as fossil fuels and wood (ATSDR, 1995).
Indeno[1,2,3-c,d]pyrene is found in gasoline engine exhaust and
tobacco smoke (IARC, 1983). In conclusion, the dominant com-
pounds of both of gaseous and particle phases were probably
originated from coal combustion, burning of organic materials,
gasoline or diesel engine exhaust emissions.
Table 1
Proposed TEFs for individual PAHs.
Compound Nisbet and
LaGoy
(1992)
OEHHA
(1994)
Muller
(1997)
Malcolm
and Dobson
(1994)
Larsen and
Larsen
(1998)
This
Study
Nap 0.001 – – – – 0.001a
AcPy 0.001 – – 0.001 – 0.001a
Acp 0.001 – – 0.001 – 0.001a
Flu 0.001 – – – – 0.001a
PA 0.001 – 0.00064 0.001 0.0005 0.001a
Ant 0.01 – – 0.01 0.0005 0.01a
FL 0.001 – – 0.001 0.05 0.001a
Pyr 0.001 – 0 0.001 0.001 0.001a
CYC – – 0.012 – 0.02 0.02b
BaA 0.1 0.1 0.014 0.1 0.005 0.1a
Chry 0.01 0.01 0.026 0.01 0.03 0.01a
BbF 0.1 0.1 0.11 0.1 0.1 0.1a
BkF 0.1 0.1 0.037 0.1 0.05 0.1a
BaP 1 1 1 1 1 1a
BeP – – 0 0.01 0.002 0.002b
Ind 0.1 0.1 0.067 0.1 0.1 0.1a
DahA 1 – 0.89 1 1.1 1a
BghiP 0.01 – 0.012 0.01 0.02 0.01a
ATT – – 0.28 – 0.3 0.3b
a The TEF values proposed by Nisbet and Lagoy (1992).
b The TEF values proposed by Larsen and Larsen (1998).
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People spend majority of time indoors. The mean (and 5th to
95th percentile range) percentages of time spent indoors, out-
doors, and in transit were 74 (63–83), 22 (11–35), and 3 (2–6),
respectively, for the study participants. Therefore, exposure to PAH
compounds indoors is important. There are indoor PAH sources
such as cooking, tobacco smoking, and indoor heating (Zhou and
Zhao, 2012) which may result in higher indoor air concentrations.
However, the mean indoor/outdoor ratio for BaPeq concentration
was reported to range from 0.94 to 1.11 (5th to 95th percentile).
Moreover, reduction in the ambient air PAH concentrations was
predicted to be the only method that would result in significant
mitigation of risk for urban households (Zhou and Zhao, 2012).
Consequently, the use of ambient air concentrations for exposure
indoors in this study probably did not introduce a considerable
error into the estimated risk levels.
Pufulete et al. (2004) reported that the use of TEFs is the more
preferred method over the comparative potency of mixtures and
the use of BaP as a surrogate for the determination of inhalation
carcinogenic potencies of relevant PAHs in ambient air. In this
approach, toxicity of each PAH compound is expressed relative to
the toxicity of BaP, the most studied and potent PAH compound.
Petry et al. (1996) reported that TEF values developed by Nisbet
and LaGoy (1992) were proved to be a better set than the other
published sets. Thus, PAH concentrations were converted to their
BaPeq concentrations using the set by Nisbet and LaGoy (1992) in
this study. However, values from Larsen and Larsen (1998) were
also employed for those that are not in the set. The results showed
that gaseous phase PAH concentrations were 43.5 times higher
than that of particle phase, however, the particle phase BaPeq
concentrations were at least 4 times higher than gaseous phase
BaPeq concentrations. This is because the gaseous phase PAH
compounds have lower molecular weights and TEF values than
the particle phase PAH compounds. The BaPeq concentrations
measured in this study are similar to those measured in Kocaeli,
Turkey (Gaga et al., 2012), are in the range of those measured in
Asian countries (Chang et al., 2006), lower than those measured at
road intersections in Tianjin, China (Hu et al., 2007) and at a
highway toll station in Taiwan (Tsai et al., 2004), higher than those
measured in in Zaragoza, Spain (Callen et al., 2007) and in the UK
(Delgado-Saborit et al., 2011).
Fig. 1. PAH concentrations of (a) gaseous phase and (b) particle phase, (c) BaPeq concentrations of gaseous phase and (d) particle phase.
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Some of the PAHs have been classified as Group 1, 2A, and 2B
carcinogens by International Agency for Research on Cancer (IARC)
based on various levels of animal and human studies. Eight of the
priority PAHs (16 PAHs listed by the USEPA, 2010) including BaA,
BaP, BbF, BkF, Chry, DahA, Ind, and Nap were classified as possible
(2B) human carcinogens (IARC, 2004). In this study, 11 percent of
the gaseous phase PAHs and 48 percent of the particle phase PAHs
contained in ambient air were human carcinogens. Vu et al. (2011)
analyzed PAH samples collected from downtown, residential, and
industrial areas in Ulsan, Korea. Twenty to 45 percent of the total
PAHs contained in PM10 was human carcinogens, with the highest
fraction found in downtown area, whereas 55–80 percent of the
total PAHs were not-classified or non-carcinogenic PAHs.
Five activity levels (rest, sedentary, light, moderate, and heavy
activities) were considered in this study. The highest contribution
to inhalation risks was from sedentary category (activities done
sitting down) while the lowest was due to heavy activities such as
playing football, aerobics, or doing heavy work such as digging
soil. The assumed respiration rates for heavy and sedentary
activities were 3.2 m3/h and 0.5 m3/h, respectively (USEPA, 1997).
However the average time spent with sedentary activities was
37 times higher than with heavy activities. In support, statistics
show that 77 percent of 414 year-olds in Turkish population do
not participate in sport activities (TUIK, 2007).
Results of the uncertainty analysis in the simulated exposure
are shown in Table 4 as descriptive statistics for a chosen set of
distribution percentiles and the mean. Relative standard deviation
(RSD) was calculated as the measure of variation for an estimated
population parameter. RSD values were o4 percent for the
median, mean, and 95th percentile, whereas it was r12 percent
Table 2
Descriptive statistics for individual exposure (ng/kg-day) and carcinogenic risks.
Inhalation route Min Median Mean Standard deviation 95th Percentile Max
Based on mean BaPeq concentration
Exposure 1.5 4.1 4.2 1.1 5.8 7.0
Riska 5.89106 1.60105 1.63105 4.18106 2.25105 2.74105
Riskb 4.60104 1.25103 1.27103 3.27104 1.76103 2.14103
Based on median BaPeq concentration
Exposure 1.0 2.8 2.9 0.7 4.0 4.8
Riska 4.05106 1.10105 1.12105 2.88106 1.55105 1.89105
Riskb 3.16104 8.58104 8.74104 2.25104 1.21103 1.47103
Based on 95th percentile BaPeq concentration
Exposure 5.8 15.8 16.0 4.1 22.3 27.2
Riska 2.27105 6.17105 6.28105 1.62105 8.69105 1.06104
Riskb 1.78103 4.82103 4.91103 1.26103 6.78103 8.27103
Dermal route Min Median Mean Standard deviation 95th Percentile Max
Based on mean BaPeq concentration
Exposure 0.103 0.120 0.121 0.008 0.135 0.140
Risk 1.23106 1.47106 1.46106 9.02108 1.62106 1.68106
Based on median BaPeq concentration
Exposure 0.090 0.107 0.106 0.007 0.118 0.122
Risk 1.08106 1.28106 1.27106 7.88108 1.42106 1.47 106
Based on 95th percentile BaPeq concentration
Exposure 0.281 0.334 0.332 0.021 0.370 0.383
Risk 3.37106 4.01106 3.98106 2.47107 4.43106 4.59106
a Carcinogenic risk using the SF value by CalEPA (2005).
b Carcinogenic risk using the SF value by WHO (1987).
Table 3
Fitted distributions for exposure-risk model input variables.
Fitted distribution Distribution parametersa ADb KSc
BaPeq gaseous phase concentration (ng/m3) Lognormal Mean¼3.29 0.155 0.124
SD¼7.18
BaPeq particle phase concentration (ng/m3) Extreme value Mode¼24.20 0.597 0.123
Scale¼24.20
Body weight (kg) Normal Mean¼73.31 0.439 0.095
SD¼12.82
Body surface area (m2) Normal Mean¼0.13 0.382 0.089
SD¼0.01
Sedentary activity (h/day) Lognormal Mean¼3.34 0.236 0.081
SD¼1.54
Rest (h/day) Extreme value Mode¼0.47 1.027 0.121
Scale¼0.78
Light activity (h/day) Extreme value Mode¼0.84 0.631 0.094
Scale¼0.74
Heavy activity (h/day) Normal Mean¼0.09 13.61 0.392
SD¼0.21
In transit (h/day) Beta Alpha¼1.91 0.242 0.068
Beta¼9.31
Scale¼5.92
Inhalation chronic daily intake (ng/kg-day) Gamma Scale¼2.42 1.95 0.011
Shape¼1.83
Dermal chronic daily intake (ng/kg-day) Weibull Scale¼0.07 1.509 0.027
Shape¼1.79
a SD: Standard deviation.
b AD: Anderson–Darling, test statistic values of o0.5 indicate a significant fit.
c KS: Kolmogorov–Smirnov, test statistic values of o0.05 indicate a significant fit.
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for the 5th percentile for both of the exposure routes, indicating
uncertainties arisen from the Monte Carlo process were low.
In this study, all PAH samples were collected during the heating
period between October 2009 and March 2010. Limited number of
studies that exist in literature have documented PAH concentra-
tions in different seasons in Turkey. Esen et al. (2006) analyzed
atmospheric samples which were collected between July 2004
and May 2005 in Bursa, Turkey. The measured average seasonal
concentrations were 55740, 1877202, 6457588, and 1487
132 ng/m3 for summer, fall, winter, and spring, respectively, which
corresponds to a heating period (winterþfall)/non-heating period
(summerþspring) ratio of 4, and a winter to the average of the
rest of the year ratio of 5. Ari (2008) studied atmospheric PAH
concentrations in Eskisehir, Turkey. The mean total PAH concen-
tration in winter and summer was found as 1185 and 178 ng/m3,
respectively. Hence, winter/summer ratio was about 7. The ratio of
heating to non-heating period total PAH concentrations in Kocaeli
was determined as 4 (Gaga et al., 2012). The estimated inhala-
tion exposures ranged between 0.037 and 24.4 ng/kg-day, while
the range for dermal exposure was from 3.70106 to 0.25 ng/kg-
day for the heating period in this study. If non-heating period
exposures were to be roughly estimated by using the concentra-
tion ratio of four (Esen et al., 2006; Gaga et al., 2012), they would
range between 9.25103 and 6.1 ng/kg-day, and 9.25107
and 0.063 ng/kg-day for inhalation and dermal exposures, respec-
tively. Consequently, carcinogenic risks associated with chronic
year-around inhalation and dermal exposures can be estimated as
1.25 folds of the risks estimated for the heating period.
In this study, two different SF values by CalEPA (2005) and
WHO (1987) were used to calculate risk for inhalation. SF for
inhalation exposure was estimated as 3.9 (mg/kg-day)1 by
CalEPA (2005). The SF for inhalation was obtained on the basis of
the data for respiratory tract tumors from inhalation exposure in
hamsters. Also, a unit risk for BaP (URBAP) was estimated to be
8.7105 per ng/m3 based on epidemiological data from studies
in coke-oven workers by WHO (1987). The URBaP is the calculated
theoretical upper limit possibility of contracting cancer when
exposed to BaP at a concentration of one microgram per cubic
meter of air for a 70-year lifetime (CalEPA, 2005). When URBAP was
converted to a slope factor, SF for inhalation can be found as to
304.5 (mg/kg-day)1. The 95th percentile inhalation risk was
calculated as 4.12105 by using SF by CalEPA (2005) which is
higher than the general acceptable carcinogenic risk level of 106
but lower than the level of 104 applied for some pollutants such
as arsenic, indicating considerable potential health risk. The 95th
percentile inhalation risk calculated using SF by WHO (1987) is
3.33103, indicating high potential health risk. The difference in
the SF values is around two orders of magnitude due to assump-
tions and procedures which were applied to determine the SF
values. Hu et al. (2007) analyzed PAH samples for traffic policemen
in Tianjin, China. They used a cancer slope factor of 3.14 (mg/kg/
day)1. The 95th percentile risk value estimated by using a
high average winter/summer ratio of PAH concentrations (W¼10)
was 1.36104. Jia et al. (2011) conducted a study in Beijing,
China. Samples of PAHs were collected in nonsource control and
source control periods. The URBaP values by CalEPA (2005) and
WHO (1987) were used to calculate risk for inhalation. The results
showed that lifetime excess carcinogenic risk range from 6.5
106 to 5.2104 for the source control period, and from 12
106 to 9.6104 for the nonsource control period. In Turkey,
Gaga et al. (2012) measured PAH compounds during heating and
non-heating periods, and estimated associated carcinogenic risks
for inhalation in an industrialized city, Kocaeli. The gasþparticle
phase PAH concentrations ranged from 6.2 ng/m3 (DahA) to
98.6 ng/m3 (PA) in the heating period, and from 3 ng/m3 (BaA) to
35.1 ng/m3 (PA) in the non-heating period. Unit risk of 8.7105
per ng/m3 for a lifetime (70 years) exposure to BaP recommended
by WHO (1987) was used to calculate cancer risk for the route of
inhalation. The results showed that estimated total cancer risk
levels were 2.92103 in the heating period and 1.15103 in
the non-heating period. However, Gaga et al. (2012) estimated
these risk levels using assumed values such as the mean values for
the input variables except for the concentrations.
Two different SF values for BaP dermal contact exposure were
estimated as 37.47 (mg/kg-day)1 based on incidence of skin
tumors in mice (Schmahl et al., 1977) and 23.5 (mg/kg-day)1
based on a gastrointestinal absorption factor of 0.31(Burmaster
and Crouch, 1997; RAIS, 2006). These studies gave researchers
guidance but there is no recommended SF for BaP dermal contact
exposure. An SF value for ingestion exposure is recommended as
12.0 (mg/kg-day)1 by CalEPA (2005). So, this value was used in
our study to estimate carcinogenic risk for dermal exposure. The
95th percentile dermal risk was estimated as 1.63106 which is
only a fraction higher than the general acceptable carcinogenic
risk level.
Fig. 2. Fitted probability distributions of cancer risk (a) based on SF by CalEPA
(2005) for inhalation exposure, and (b) based on SF by CalEPA (2005) for dermal
exposure.
Table 4
Uncertainty in distributional statistics of simulated exposure (ng/kg-day).
Exposure
type
Statistic 5th
Percentile
50th
Percentile
Mean 95th
Percentile
Inhalation Minimum 0.394 3.537 4.109 10.430
Median 0.623 3.773 4.393 11.622
Mean 0.638 3.758 4.407 11.606
SDa 0.078 0.100 0.108 0.419
Maximum 0.856 4.008 4.716 12.55
Dermal Minimum 0.0071 0.0562 0.0619 0.1333
Median 0.0092 0.06 0.0647 0.1436
Mean 0.0097 0.0599 0.0648 0.1438
SDa 0.0011 0.0017 0.0011 0.0042
Maximum 0.0127 0.0647 0.0682 0.1587
a SD: Standard deviation.
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The estimated risks for inhalation route are at least an order of
magnitude higher than those of dermal contact route. Considera-
tion of only the particle-phase concentrations, low skin perme-
ability, and small exposed surface area due to the season are the
probable reasons for the difference between calculated risks for
inhalation and dermal exposure routes. Chen and Liao (2006)
estimated inhalation and dermal risks for adults, children, and
infants in Taiwan, China. The geometric mean risk for inhalation
and dermal exposure routes were reported as 1.04104 and
3.85105, respectively. The risks for adults are close to the
values estimated in this study.
Sensitivity analysis was conducted to determine the influence
of each input variable seperately for inhalation and dermal routes
as the percent contribution to variance. Although there are slight
differences, the contribution of gaseous phase BaPeq concentration
for inhalation risk estimated by the two SF values is around 90
percent as the most significant variable. The contribution of
particle phase PAH concentration was the most influential variable
with 93 percent for dermal contact. In other words, variation in
the PAH concentrations is the largest source of variation in
exposure-risk, therefore, they play the most important role in
determining the exposure-risks.
5. Conclusion
Carcinogenic risk levels were assessed associated with dermal
contact and inhalation of 19 PAH compounds in Balikesir during a
heating period. The mean gaseous and particle phase concentra-
tions were 432 and 187 ng/m3, respectively. Monte Carlo simula-
tion was implemented to estimate exposure and carcinogenic risks
via both routes of inhalation and dermal contact for Balikesir
population in addition to the individual risks for the study
participants. The estimated risks showed that inhalation exposure
level is more significant than that of dermal contact route. The
carcinogenic risks associated with inhalation reaches levels that
are greater than the highest acceptable risk (104) when esti-
mated using the SF by WHO (1987), while the risks for dermal
contact were significantly lower. Sensitivity analysis suggests that
the PAH concentrations play the most important role in determin-
ing the exposure-risks.
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